Prospective randomized trial comparing paclitaxel releasing balloon with everolimus eluting stent for the small coronary vessels

Prospective randomized trial comparing paclitaxel releasing balloon with everolimus eluting stent for the small coronary vessels - ORB study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033709

Enrollment

322

Registered

2018-08-15

Start date

2018-01-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

drug coating balloon follow up duration 12 months follow up angiogram will be performed after 8months from initial therapy everolimous eluting stent follow up duration 12 months follow up angiogra

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with coronary artery disease less than 2.75mm in diameter

Exclusion criteria

Exclusion criteria: Acute coronary syndrome heart failure person requiring dialysis pregnant women in stent restenosis case severe calcified vessel contraindicated to antiplatelet therapy

Design outcomes

Primary

Measure	Time frame
percentage diameter stenosis of the target vessel at follow up angiography	—

Secondary

Measure	Time frame
all cause death acute coronary syndrome revascularization	—

Countries

Japan

Contacts

Public ContactHiroshi Tamura

The Juntendo University Nerima Hospital Department of Cardiology

tamura5155@gmail.com03-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026